其他PARP抑制剂治疗新诊断晚期卵巢癌的研究进展.pdfVIP

其他PARP抑制剂治疗新诊断晚期卵巢癌的研究进展 仅供内部销售培训使用 CN-38534 2020/10/17 Niraparib治疗新诊断的晚期卵巢癌 (PRIMA/ENGOT-OV26/GOG-3012) A. Gonzá lez-Martín,1 B. Pothuri,2 I. Vergote,3 R.D. Christensen,4 W. Graybill,5 M.R. Mirza,6 C. McCormick,7 D. Lorusso,8 P. Hoskins,9 G. Freyer,10 F. Backes,11 K. Baumann,12 A. Redondo,13 R. Moore,14 C. Vulsteke,15 R.E. OCearbhaill,16 B. Lund,17 Y. Li,18 D. Gupta,18 B.J. Monk19 1Grupo Españ ol de Investigació n en Cá ncer de Ovario (GEICO), Medical Oncology Department, Clínica Universidad de Navarra, Madrid, Spain; 2Gynecologic Oncology Group (GOG), Department of Obstetrics/Gynecology, Perlmutter Cancer Center, NYU Langone Cancer Center, New York, NY, USA; 3Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Department of Gynaecology and Obstetrics, Division of Gynaecologic Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium; 4 Nordic Society of Gynaecological Oncology (NSGO), Research Unit of General Practice, Institute of Public Health, University of Southern Denmark, Odense, Denmark; 5 GOG, Gynecologic Oncology, Medical University of South Carolina, Charleston, SC, USA; 6NSGO, Rigshospitalet–Copenhagen University Hospital, Copenhagen, Denmark; 7GOG, Legacy Medical Group Gynecologic Oncology, Portland, OR, USA; 8Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Fondazione IRCCS National Cancer Institute of Milan, Milan, Italy; 9US Oncology Research (USOR), Department of Medical Oncology, BC Cancer – Vancouver, Vancouver, BC, Canada; 10Groupe dInvestigateurs Nationaux pour lEtude des Cancers Ovariens (GINECO), HCL Cancer Institute Department of Medical Oncology Lyon University, Lyon, France; 11Division of Gynecologic Oncology, Ohio State University, Columbus, OH, USA; 12Arbeitsgemeinschaft Gynä kologische Onkologie (AGO), Department of Gynecology